- RESEARCH HIGHLIGHT
Opening up a pathway for disease modification in osteoarthritis
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 18, 497 (2019)
doi: https://doi.org/10.1038/d41573-019-00098-5
References
Li, T. et al. TGF-β type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis. Sci. Transl Med. 11, eaan2585 (2019)